Invitation to provide advice and suggestions for CIHR's Policy in Development - Access to Products of Research

The mandate of CIHR is to:

"excel in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system." 1

One of the key elements of this mandate is to accelerate the use of new health research findings for the benefit of Canadians. Health research and the subsequent products of this research are important for advancing the health of the population. Access to the physical products and results of publicly funded research stimulates the transfer of new knowledge and innovation for public benefit. The goal of all research access policies has been best described by the U.S. National Academies of Sciences:

"Universal adherence, without exception, to a principle of full disclosure and unrestricted access to data and materials that are central or integral to published findings will promote cooperation and prevent divisiveness in the scientific community, maintain the value and prestige of publication, and promote the progress of science." 2

"Blueprint", CIHR's strategic plan, identified several core values including public interest, integrity, freedom of inquiry, collaboration, transparency and accountability that guide CIHR and influence all aspects of the organization as well our relationships with others. These values also assure Canadians that their investments in health research are made wisely. CIHR's decision to develop policies that increase access to the products of research was influenced by our commitment to these core values.

"CIHR recognizes that the primary purpose of all research in the public domain is the creation of new knowledge in an environment that embodies the principles of freedom of inquiry and unrestricted dissemination of research results." 3

The aim of this policy is to increase access to the discoveries made by CIHR-funded researchers. CIHR believes that timely access to research products and materials, and information will stimulate the development of new health products that will benefit the health of Canadians as well as the global population.

CIHR recognizes that the area of access to the products of research is complex and requires due consultation with stakeholders. CIHR is interested in receiving the opinions and suggestions of the health research community in order to help guide policy development.

The deadline for submissions is May 15, 2006.

Click here to take the survey (survey is closed)

If you have any questions related to CIHR's plans to develop a policy concerning Access to the Products of Research, please contact:

Geoff Hynes
Research Officer
Canadian Institutes of Health Research
Tel.: (613) 952-8965
Email: ghynes@cihr-irsc.gc.ca


1 Bill C-13: The Canadian Institutes of Health Research Act. April 13, 2000.
2 Sharing publication-related data and materials responsibilities of authorship in the life sciences. Committee on Responsibilities of Authorship in the Biological Sciences, Board on Life Sciences, Division on Earth and Life Studies. National Research Council of the National Academies, The National Academies Press, Washington , D.C. http://www.nap.edu.
3 Investing in Canada 's Future: CIHR's Blueprint For Health Research and Innovation ( 2003/04 - 2007/08), Ottawa , January 2004.